(PALATINE, Ill.)Acura Pharmaceuticals Inc. said Monday it received a $5 million milestone payment from King Pharmaceuticals Inc. for meeting the main goals of a late-stage study on pain relief dru...READ MORE
(NEW YORK)The Standard & Poor's 500 Index wobbled at midday Friday following the previous session's steep drop, as investors remained jittery over a fresh record in oil prices but go...READ MORE
(NEW YORK)Pharmaceutical stocks may have ended Wednesday's trading session mostly in the green, but stocks are still down substantially year to date, and a JPMorgan analyst cautioned tha...READ MORE
(PALATINE, Ill.)Acura Pharmaceuticals Inc. said Tuesday that it late-stage trial of its pain pill Acurox met its goal. The drug contains the prescription pain drug oxycodone, but with other ingred...READ MORE
(PITTSBURGH)Mylan Inc. said Monday the Food and Drug Administration approved the company's application to sell generic capsules of Sonata, an insomnia treatment. The company will immediate...READ MORE
(PALATINE, Ill.)Acura Pharmaceuticals Inc. said Tuesday that King Pharmaceuticals Inc. has paid the drug maker $3 million to exercise its option to license a third opioid pain medicine using Acura...READ MORE
(NEW YORK)The pharmaceutical sector slipped lower Tuesday, as drugmaker Wyeth said its first-quarter profit declined and generic competition slashed sales of blockbuster heartburn drug Proto...READ MORE